Related Experiment Video
Updated: Aug 14, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Predictive value of systemic inflammatory response index for coronary artery disease and angiographic severity: a
Yizhe Wang1,2,3, Jinxiang Huang1,2,3, Peng Zheng1,2,3
1Department of Cardiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Insights
Systemic inflammatory response index (SIRI) is linked to coronary artery disease (CAD) severity in East Asians. A predictive model using SIRI, albumin, and LVEF shows moderate discrimination for CAD risk stratification.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Systemic inflammation is crucial in coronary artery disease (CAD).
- The Systemic Inflammatory Response Index (SIRI), a composite biomarker, needs further study regarding its association with angiographic CAD severity, especially in East Asian populations.
- This study investigates SIRI's relationship with CAD presence and severity in a Chinese cohort.
Purpose of the Study:
- To explore the association between SIRI and the presence of angiographic coronary artery disease (CAD).
- To evaluate the relationship between SIRI and the severity of angiographic CAD.
- To develop and validate a predictive model for CAD risk stratification using SIRI in a southeastern Chinese cohort.
Main Methods:
- Retrospective enrollment of adult inpatients undergoing coronary angiography in Wenzhou, China.
- CAD defined as ≥50% stenosis in major epicardial coronary arteries.
- Multivariable logistic regression and receiver-operating characteristic (ROC) curve analysis were used to identify predictors and evaluate a predictive model incorporating SIRI, albumin, and left ventricular ejection fraction (LVEF).
Main Results:
- SIRI was significantly higher in patients with CAD and increased with CAD severity, particularly in myocardial infarction groups.
- SIRI demonstrated the highest area under the curve (AUC) for CAD discrimination among evaluated inflammatory indices.
- The albumin + LVEF + SIRI model showed moderate discrimination for angiographic CAD (AUC = 0.740) and improved upon the albumin + LVEF model.
Conclusions:
- SIRI is independently associated with angiographic CAD presence and severity in the studied cohort.
- A predictive model integrating SIRI, albumin, and LVEF offers moderate discrimination for CAD risk stratification.
- This model serves as a preliminary, internally validated, hypothesis-generating tool for risk stratification.
Background:
Systemic inflammation plays a pivotal role in coronary artery disease (CAD). Systemic inflammatory response index (SIRI), a composite biomarker derived from neutrophil, monocyte, and lymphocyte counts, has been poorly studied for its association with angiographic CAD severity in East Asians. This study aimed to explore the relationship between SIRI and the presence and angiographic severity of CAD, and to develop a predictive model for risk stratification in a southeastern Chinese cohort.
Methods:
We retrospectively enrolled adult inpatients who underwent coronary angiography in Wenzhou, China, between June 2023 and March 2024. CAD was defined as ≥50% stenosis in at least one major epicardial coronary artery. Baseline clinical, laboratory, echocardiographic, and angiographic data were collected. SIRI and other inflammation-based indices were calculated from admission blood counts. Multivariable logistic regression was used to identify independent CAD predictors, and the final CAD model was evaluated using analysis of receiver-operating characteristic curves, internal bootstrap validation, calibration assessment, decision curve analysis, added predictive value analysis, stability testing, and subgroup analyses.
Results:
Among 394 patients, SIRI was higher in patients with CAD and increased across CAD phenotypes, with the highest values in the myocardial infarction groups. SIRI showed the highest AUC among the evaluated inflammatory indices for CAD discrimination. Albumin, left ventricular ejection fraction (LVEF), and SIRI remained independently associated with CAD. The albumin + LVEF + SIRI model showed moderate discrimination for angiographic CAD (AUC = 0.740, 95% CI: 0.682-0.797), improved the albumin + LVEF model (delta AUC = 0.045; DeLong p = 0.024), showed acceptable internal calibration, and remained stable when SIRI was modeled as untransformed, log10-transformed, or quartile-based values. A low-costnomogram (AUC = 0.74) showed favorable internal calibration and parallel performance for angiographic severity (AUC = 0.719).
Conclusions:
SIRI was independently associated with angiographic CAD and disease severity in this cohort. A predictive model integrating SIRI, albumin, and LVEF showed moderate discrimination and should be considered a preliminary, internally validated, hypothesis-generating risk-stratification framework rather than a clinically deployable decision-making tool.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction